Cardlytics, Inc.

Cardlytics, Inc.

CDLXยทNASDAQ

$0.91

+0.0000%
Communication ServicesAdvertising Agencies

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

At a Glance

Live Snapshot
Market Cap$50.36M
EPS-1.9500
P/E Ratio-0.47
Earnings Date05/05/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

Medium confidence

Valuation multiple is compressed (P/E -0.5).

Valuation inputs: P/E -0.5, earnings yield N/A, momentum 0.0%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE +15.9%, ROIC -22.6%).

Profitability stack: net margin -44.4%, ROE +15.9%, ROIC -22.6%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Downside profile is elevated and scenario stress-testing is essential.

Risk factors: liabilities/assets +102.3%, momentum 0.0%, net margin -44.4%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

cdlx

Cardlytics, Inc. Market vs Earnings Trajectory

CDLX ยท NASDAQ

Loading price and EPS data...

Cardlytics, Inc.

Cardlytics, Inc. Fair Value Envelope

CDLX ยท NASDAQ

Our analysis suggests that CDLX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $0.9145, this represents a potential HIDDEN relative to our calculated worth for Cardlytics, Inc..

Intrinsic Value
Current Price: $0.9145
3Y-86.0%
5Y-9.0%
10Y-64.0%
3Y-22.0%
5Y+25.0%
10Y+107.0%
3Y-78.0%
5Y+87.0%
10Y+37.0%
3Y-117.0%
5Y-222.0%
10Y-129.0%
3Y-113.0%
5Y-150.0%
10Y-125.0%
3Y-59.0%
5Y-32.0%
10Y+229.0%
Cardlytics, Inc.

Cardlytics, Inc. Profit Bridge

CDLX ยท NASDAQ
Revenue233.27M
Cost of Goods Sold (128.19M)
Gross Profit105.08M
Operating Expenses (152.22M)
Operating Income-47.14M
Interest Expense (10.63M)
Other Income/Expense-56.35M
Pretax Income-103.49M
Income Tax (0.00)
Net Income-103.49M
Net Income
-103.49M

Profitability Analysis

Gross Margin

45.0%

Strong gross margins indicate healthy pricing and efficient production or service delivery.

Operating Margin

-20.2%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-44.4%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

45.05%
Gross Profit Margin
4%
3Y+19.0%
5Y+33.0%
10Y+26.0%
-20.21%
Operating Profit Margin
-71%
3Y-87.0%
5Y-30.0%
10Y-59.0%
-44.36%
Net Profit Margin
-35%
3Y-72.0%
5Y+50.0%
10Y-34.0%
1590.17%
Return on Equity
-688%
3Y-823.0%
5Y-4610.0%
10Y+4455.0%
-36.23%
Return on Assets
-25%
3Y-46.0%
5Y+176.0%
10Y-58.0%
-22.57%
Return on Invested Capital
-66%
3Y-78.0%
5Y+45.0%
10Y-81.0%
CDLX

Cardlytics, Inc. Cash Conversion Engine

CDLX ยท NASDAQ
Net Income-103.49M
Depreciation & Amortization27.41M
Stock-Based Compensation28.13M
Change in Working Capital5.71M
Others51.53M
Capital Expenditures-480.00K
Free Cash Flow8.81M

Cash Flow Quality Analysis

FCF Conversion Rate

-8.5%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

5.2%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+131.3%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$5.71M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

cdlx

Cardlytics, Inc. Funding & Solvency Profile

CDLX ยท NASDAQ
Cash & Cash Equivalents48.72M
Net Receivables85.26M
Inventory0.00
Other Current Assets3.30M
Total Current Assets137 M
Property, Plant & Equipment6.97M
Goodwill & Intangible Assets115.86M
Long-Term Investments0.00
Other Non-Current Assets25.53M
Total Non-Current Assets33 M
Total Assets
285.64M

Financial Health Analysis

Current Ratio

1.75x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Working Capital

59 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

48% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

cdlx

Cardlytics, Inc. Street Expectations Map

CDLX ยท NASDAQ

Wall Street analysts project that CDLX stock may experience modest gains over the coming 12 months. The consensus 1-year price target stands at 1.00, with estimates ranging from a low of 1.00 to a high of 1.00.

Lowest Target
1.00
9.35%
Consensus Target
1.00
9.35%
Highest Target
1.00
9.35%

The consensus 1-year price target stands at 1.00, with estimates ranging from a low of 1.00 to a high of 1.00.

Analyst Consensus Analysis

Upside Potential

+9.3%

Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

High

Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

cdlx

Cardlytics, Inc. Insider Positioning

CDLX ยท NASDAQ

During the last 12 months, insiders have sold $1.00M worth of CDLX shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

226.9K

241.21K

Net Activity

-241K

-$241K

3-6 Months

Bought

0

0.00

Sold

117.9K

112.94K

Net Activity

-113K

-$113K

6-9 Months

Bought

0

0.00

Sold

22.4K

50.85K

Net Activity

-51K

-$51K

9-12 Months

Bought

0

0.00

Sold

514.1K

595.69K

Net Activity

-596K

-$596K

Top Buyers

No buying activity

Top Sellers

1
SC

Sosin Clifford

10 Percent Owner

400.0K sharesโ€ข2 transactions

$453K

2
GA

Gupta Amit

Director, Officer: Chief Executive Officer

372.8K sharesโ€ข9 transactions

$403K

3
DA

Desieno Alexis

Officer: Chief Financial Officer

50.5K sharesโ€ข4 transactions

$74K

4
LNH

Lynton Nicholas Hollmeyer

Officer: Chief Legal & Privacy Officer

57.9K sharesโ€ข4 transactions

$70K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $1.00M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$241K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

0.00%
Dividend Yield
3Y-
5Y-
10Y-
ย 

cdlx Dividend History

CDLX
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%